Prelude Therapeutics Incorporated
Selective Inhibitors Of Protein Arginine Methytransterase 5 (PRMT5)

Abstract:

The disclosure is directed to compounds of Formula I ##STR00001## Pharmaceutical compositions comprising compounds of Formula I, as well as methods of their use and preparation, are also described.